What type of study is this?

This is a Animal Study study (also classified as: In Vitro Study).

Development of Mucopenetrating Pegylated Liposomes Functionalized with Sodium Taurocholate for Enhanced Oral Insulin Delivery

View Full Paper

Ask AI

Bookmark

Authors

Novel oral insulin system using PEGylated liposomes improves bioavailability and efficacy, suggesting a non-invasive alternative.

Novel oral insulin formulation improves bioavailability and enhances insulin delivery.
In vivo studies showed significant therapeutic efficacy in diabetic animal models.
PEGylated liposomal technology protects insulin from degradation in the gastrointestinal tract.
Sodium taurocholate modulates intestinal permeability, facilitating better absorption.

Vikal et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Novel oral insulin system using PEGylated liposomes improves bioavailability and efficacy, suggesting a non-invasive alternative.

Novel oral insulin formulation improves bioavailability and enhances insulin delivery.
In vivo studies showed significant therapeutic efficacy in diabetic animal models.
PEGylated liposomal technology protects insulin from degradation in the gastrointestinal tract.
Sodium taurocholate modulates intestinal permeability, facilitating better absorption.

Vikal et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark